Liquid chromatography-tandem mass spectrometry method for determination of panel of neurotransmitters in cerebrospinal fluid from the rat model for tauopathy

Talanta

Volumn 119, Issue , 2014, Pages 284-290

  Kovac, Andrej ^a,b   Somikova, Zuzana ^a   Zilka, Norbert ^a,b   Novak, Michal ^a,b  

^a INSTITUTE OF NEUROIMMUNOLOGY   (Slovakia)

^b AXON Neuroscience SE ^*  (Slovakia)

Author keywords

Alzheimer's disease; Cerebrospinal fluid; Neurotransmitters; Rat model; Tau protein; UPLC MS

Indexed keywords

AMINO ACIDS; BRAIN; CHEMICAL DETECTION; CHLORINE COMPOUNDS; COLUMN CHROMATOGRAPHY; DIAGNOSIS; HIGH PRESSURE LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETRY; METABOLITES; NEURODEGENERATIVE DISEASES; NEUROPHYSIOLOGY; NOREPINEPHRINE; RATS;

ALZHEIMER'S DISEASE; NEUROTRANSMITTERS; RAT MODEL; TAU PROTEINS; UPLC/MS;

CEREBROSPINAL FLUID;

3,4 DIHYDROXYPHENYLACETIC ACID; 4 AMINOBUTYRIC ACID; ADRENALIN; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; DOPAMINE; GLUTAMIC ACID; HISTAMINE; HOMOVANILLIC ACID; NEUROTRANSMITTER; NORADRENALIN; TAU PROTEIN;

5-HIAA; 5-HYDROXYINDOLEACETIC ACID; 5-HYDROXYTRYPTAMINE; AD; ADR; ALZHEIMER DISEASE; ANIMAL; ARTICLE; CEREBROSPINAL FLUID; DA; DISEASE MODEL; GLU; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; HIS; HOMOVANILIC ACID; IS; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; LOD; LOQ; METHODOLOGY; NADR; NT; RAT; RAT MODEL; REPRODUCIBILITY; SER; STANDARD; TANDEM MASS SPECTROMETRY; TAUOPATHY; TRANSGENIC RAT; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY; UPLC/MS; VALIDATION STUDY; Γ-AMINOBUTYRIC ACID;

3,4-DIHYDROXYPHENYLACETIC ACID; 5-HIAA; 5-HYDROXYINDOLEACETIC ACID; 5-HYDROXYTRYPTAMINE; AD; ADR; ADRENALINE; ALZHEIMER'S DISEASE; CEREBROSPINAL FLUID; CSF; DA; DOPAC; DOPAMINE; GABA; GLU; GLUTAMIC ACID; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; HIS; HISTAMINE; HOMOVANILIC ACID; HPLC; HVA; INTERNAL STANDARD; IS; LIMIT OF DETECTION; LIMIT OF QUANTIFICATION; LOD; LOQ; NADR; NEUROTRANSMITTERS; NORADRENALINE; NT; RAT MODEL; SER; TAU PROTEIN; ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY; UPLC; UPLC/MS; Γ-AMINOBUTYRIC ACID;

ANIMALS; CHROMATOGRAPHY, LIQUID; DISEASE MODELS, ANIMAL; LIMIT OF DETECTION; NEUROTRANSMITTER AGENTS; RATS; RATS, TRANSGENIC; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY; TAUOPATHIES;

EID: 84888607775     PISSN: 00399140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.talanta.2013.10.027     Document Type: Article

References (44)

1. D.J. Selkoe Ann. Intern. Med. 140 2004 627 638
2. T. Wyss-Coray Nat. Med. 12 2006 1005 1015
3. H. Braak, and E. Braak Acta Neuropathol. 82 1991 239 259
4. D.W. Dickson, J. Farlo, P. Davies, H. Crystal, P. Fuld, and S.H. Yen Am. J. Pathol. 132 1988 86 101
5. S. Sorensen, P. Duberstein, D. Gill, and M. Pinquart Lancet Neurol. 5 2006 961 973
6. S. Singh, A.S. Kushwah, R. Singh, M. Farswan, and R. Kaur Eur. Rev. Med. Pharmacol. Sci. 16 2012 1651 1664
7. P.J. Nestor, P. Scheltens, and J.R. Hodges Nat. Med. 10 Suppl. 2004 S34 S41
8. J.L. Griffin Curr. Opin. Chem. Biol. 10 2006 309 315
9. I. Barba, R. Fernandez-Montesinos, D. Garcia-Dorado, and D. Pozo J. Cell. Mol. Med. 12 2008 1477 1485
10. T. Egashira, F. Takayama, and Y. Yamanaka Pharmacol. Res.: Off. J. Ital. Pharmacol. Soc. 40 1999 503 508
11. M. Matsumoto, H. Togashi, M. Yoshioka, K. Morii, M. Hirokami, M. Tochihara, T. Ikeda, Y. Saito, and H. Saito Life Sci. 48 1991 823 829
12. B.J. van der Vegt, N. Lieuwes, T.I. Cremers, S.F. de Boer, and J.M. Koolhaas Horm. Behav. 44 2003 199 208
13. I. Bednar, P. Södersten, and G.A. Qireshi J. Liq. Chromatogr. 15 1992 3087 3096
14. L.G. Harsing Jr., H. Nagashima, D. Duncalf, E.S. Vizi, and P.L. Goldiner Clin. Chem. 32 1986 1823 1827
15. Y. Takemoto Jpn. J. Physiol. 41 1991 665 669
16. A. Gjerris, D.I. Barry, N.J. Christensen, O.J. Rafaelsen, Mao-Inhibitors Revisited I: Adrenaline (A) and Noradrenaline (NA) in Cerebrospinal Fluid (CSF) in Isocarboxazide treated Rats, (1985).
17. J.W. Lin, C.M. Shih, Y.C. Chen, C.M. Lin, J.T. Tsai, Y.H. Chiang, R. Shih, P.L. Chiu, K.S. Hung, Y.S. Yeh, L. Wei, W.T. Chiu, and L.Y. Yang Surg. Neurol. 72 Suppl 2 2009 S55 S65 (discussion S65)
18. G.M. Anderson, K.L. Teff, and S.N. Young Life Sci. 40 1987 2253 2260
19. K.A. Jacobson, T. Marshall, K. Mine, K.L. Kirk, and M. Linnoila FEBS Lett. 188 1985 307 311
20. R.R. Gonzalez, R.F. Fernandez, J.L. Vidal, A.G. Frenich, and M.L. Perez J. Neurosci. Methods 198 2011 187 194
21. H. Wang, E.J. Walaszczyk, K. Li, Y.W. Chung-Davidson, and W. Li Anal. Chim. Acta 721 2012 147 153
22. Y. Zhang, F.D. Tingley 3rd, E. Tseng, M. Tella, X. Yang, E. Groeber, J. Liu, W. Li, C.J. Schmidt, and R. Steenwyk J. Chromatogr. B, Anal. Technol. Biomed. Life Sci. 879 2011 2023 2033
23. T. Santa, O.Y. Al-Dirbashi, and T. Fukushima Drug Discov. Ther. 1 2007 108 118
24. H.L. Cai, R.H. Zhu, and H.D. Li Anal. Biochem. 396 2010 103 111
25. P. Song, O.S. Mabrouk, N.D. Hershey, and R.T. Kennedy Anal. Chem. 84 2012 412 419
26. X. Zheng, A. Kang, C. Dai, Y. Liang, T. Xie, L. Xie, Y. Peng, G. Wang, and H. Hao Anal. Chem. 84 2012 10044 10051
27. M. Whitmire, J. Ammerman, P. de Lisio, J. Killmer, D. Kyle, E. Mainstone, L. Porter and T. Zhang, J AnalJ. Anal. Bioanal Techniques. Tech. 2011, S4:001,http://dx.doi.org/10.4172/2155-9872.S4-001
28. N. Zilka, P. Filipcik, P. Koson, L. Fialova, R. Skrabana, M. Zilkova, G. Rolkova, E. Kontsekova, and M. Novak FEBS Lett. 580 2006 3582 3588
29. P. Koson, N. Zilka, A. Kovac, B. Kovacech, M. Korenova, P. Filipcik, and M. Novak Eur. J. Neurosci. 28 2008 239 246
30. J.A. Eckstein, G.M. Ammerman, J.M. Reveles, and B.L. Ackermann J. Neurosci. Methods 171 2008 190 196
31. D. Storga, K. Vrecko, J.G. Birkmayer, and G. Reibnegger Neurosci. Lett. 203 1996 29 32
32. N. Zilka, M. Korenova, B. Kovacech, K. Iqbal, and M. Novak Acta Neuropathol. 119 2010 679 687
33. M. Cente, P. Filipcik, S. Mandakova, N. Zilka, G. Krajciova, and M. Novak J. Alzheimer's Dis.: JAD 17 2009 913 920
34. M. Cente, P. Filipcik, M. Pevalova, and M. Novak Eur. J. Neurosci. 24 2006 1085 1090
35. N. Zilka, Z. Stozicka, A. Kovac, E. Pilipcinec, O. Bugos, and M. Novak J. Neuroimmunol. 209 2009 16 25
36. E.R. Peskind, R. Elrod, D.J. Dobie, M. Pascualy, E. Petrie, C. Jensen, K. Brodkin, S. Murray, R.C. Veith, and M.A. Raskind Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol. 19 1998 465 471
37. A.M. Palmer, N.R. Sims, D.M. Bowen, D. Neary, J. Palo, J. Wikstrom, and A.N. Davison J. Neurol., Neurosurg., Psychiatry 47 1984 481 484
38. H.J. Stuerenburg, S. Ganzer, and T. Muller-Thomsen Neuro Endocrinol. Lett. 25 2004 435 437
39. C. Vargas, M. Tannhauser, and H.M. Barros Gen. pharmacol. 30 1998 601 604
40. J.F. Stover, and A.W. Unterberg Brain Res. 875 2000 51 55
41. J. Butler, W.E. Seifert, J.W. Ferkany, N.L. Vernon, S.J. Enna, Neurochemical Analysis of Rat Cisternal Cerebrospinal Fluid, in: Neurobiology of Cerebrospinal Fluid 2, Springer US, 1983, pp. 157-162.
42. G.P. Gerrits, F.J. Trijbels, L.A. Monnens, F.J. Gabreels, R.A. De Abreu, A.G. Theeuwes, and B. van Raay-Selten Clinica chimica acta. Int. J. Clin. Chem. 182 1989 271 280
43. B.A. Shaywitz, G.M. Anderson, and D.J. Cohen Brain research, 349 1985 225 232
44. A. Soya, Y.H. Song, T. Kodama, Y. Honda, N. Fujiki, and S. Nishino Neuroscience letters, 430 2008 224 229